Efficacy of ceftriaxone and doxycycline in the treatment of early syphilis

Medecine et Maladies Infectieuses

Volumn 42, Issue 1, 2012, Pages 15-19

  Psomas, K C ^a   Brun, M ^b   Causse, A ^c   Atoui, N ^a   Reynes, J ^a   Le Moing, V ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b Département de bactériologie virologie   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Ceftriaxone; Doxycycline; Early syphilis; HIV 1; Penicillin

Indexed keywords

BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; EYE DISEASE; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROSYPHILIS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SYPHILIS; TREATMENT RESPONSE;

ADULT; ASYMPTOMATIC DISEASES; CEFTRIAXONE; DOXYCYCLINE; DRUG EVALUATION; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROSYPHILIS; PENICILLIN G BENZATHINE; RECURRENCE; RETROSPECTIVE STUDIES; SYPHILIS; YOUNG ADULT;

EID: 84855824765     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2011.10.003     Document Type: Article

References (21)

1. Douglas J.M. Penicillin treatment of syphilis: clearing away the shadow on the land. JAMA 2009, 301(7):769-771.
2. Karp G., Schlaeffer F., Jotkowitz A., Riesenberg K. Syphilis and HIV co-infection. Eur J Intern Med 2009, 20(1):9-13.
3. Lynn W.A., Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004, 4(7):456-466.
4. Tramont EC. Treponema pallidum (Syphilis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2005:chap 235.
5. Workowski K.A., Berman S.M. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55(RR-11):1-94.
6. Singh A.E., Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999, 12(2):187-209.
7. Dowell M.E., Ross P.G., Musher D.M., Cate T.R., Baughn R.E. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992, 93(5):481-488.
8. Marra C.M., Boutin P., McArthur J.C., Hurwitz S., Simpson P.A., Haslett J.A., et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000, 30(3):540-544.
9. Walter T., Lebouche B., Miailhes P., Cotte L., Roure C., Schlienger I., et al. Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis 2006, 43(6):787-790.
10. Kingston M.A., Higgins S.P. Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals. Sex Transm Infect 2004, 80(2):152-153.
11. Zetola N.M., Engelman J., Jensen T.P., Klausner J.D. Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin Proc 2007, 82(9):1091-1102.
12. Ghanem K.G., Erbelding E.J., Cheng W.W., Rompalo A.M. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis 2006, 42(6):e45-e49.
13. Yim C.W., Flynn N.M., Fitzgerald F.T. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 1985, 28(2):347-348.
14. Kang-Birken S.L., Castel U., Prichard J.G. Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virus. Pharmacotherapy 2010, 30(4):119e-122e.
15. Smith N.H., Musher D.M., Huang D.B., Rodriguez P.S., Dowell M.E., Ace W., et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15(5):328-332.
16. Blank L.J., Rompalo A.M., Erbelding E.J., Zenilman J.M., Ghanem K.G. Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sex Transm Infect 2011, 87:9-16.
17. Appleman M.E., Marshall D.W., Brey R.L., Houk R.W., Beatty D.C., Winn R.E., et al. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis 1988, 158(1):193-199.
18. Chan D.J. Syphilis and HIV co-infection: when is lumbar puncture indicated?. Curr HIV Res 2005, 3(1):95-98.
19. Poliseli R., Vidal J.E., Penalva De Oliveira A.C., Hernandez A.V. Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis. Sex Transm Dis 2008, 35(5):425-429.
20. Marra C.M., Maxwell C.L., Tantalo L.C., Sahi S.K., Lukehart S.A. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008, 47(7):893-899.
21. Dunlop E.M., Al-Egaily S.S., Houang E.T. Penicillin levels in blood and CSF achieved by treatment of syphilis. JAMA 1979, 241(23):2538-2540.